Sep 20, 2020 (CDN Newswire via Comtex) —
A new business intelligence report released by MarketsandResearch.biz with the title Global Cellulose Film Market… Companies with decent prospects trading at reasonable valuations can work wonders over time. The path to making it happen is straightforward. The former vice president and the Democrats were $187 million behind President Trump and the Republicans this spring. Now they are entering the final stretch of the campaign with a $141 million advantage.
The research also focuses on the important achievements of the market, Research & Development, and regional growth of the leading competitors operating in the market. The study includes an estimation of the business outlooks of the players and explains the nature of the competition. The report also focuses on comprehensive market revenue streams combined with growth patterns, focused on global Cellulose Film market trends, and the overall volume of the market. Report authors call attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.
NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.
DOWNLOAD FREE SAMPLE REPORT:https://www.marketsandresearch.biz/sample-request/101929
What Industry Analysis/Data Exists For The Industry?
This report covers key segments and sub-segments, key drivers, restraints, opportunities, and challenges in the market and their impact on the global Cellulose Film market growth has been analyzed. This report covers many financial metrics for the industry including profitability, market value- chain, and key trends with reference to the company’s growth, revenue, return on sales, etc.
Major competitors in the market, including the following: FUTAMURA, Hubei Golden Ring New Materials Tech Ltd, Shangdong Henglian New Materials Co., Ltd, Zhejiang Kerui, GRACE
On the basis of types, the market is primarily split into: Transparent Regenerated Cellulose Film, Color Regenerated Cellulose Film
On the basis of applications, the market covers: Food Packaging, Tobacco Packaging, Pharmaceutical Packaging, Cosmetic Packaging, Fireworks Packaging
The Cellulose Film market report includes information about the product consumption across the concerned geographies. The report has included the valuation that each region will account for as well as the market share that major topography will hold. Later, production and production value estimates by type, estimates of key producers, and production and production volume estimates by region are added in the research report. The regional consumption rate in accordance with the product types and applications is also encompassed.
Based on the region, the global market has been segmented into: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
ACCESS FULL REPORT:https://www.marketsandresearch.biz/report/101929/global-cellulose-film-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025
Key Reasons To Purchase The Market Report:
Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (firstname.lastname@example.org), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.
Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for world’s leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.
Head of Business Development
This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at email@example.com.
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.
Investing in These Stocks Now Could Make You a Millionaire Retiree
The beauty of investing is that if you start early enough and buy shares of companies with decent long-term prospects, compounding can do most of the heavy lifting when it comes to building your nest egg. Indeed, even a person of modest means can reach millionaire status by retirement by picking solid companies and letting compounding work its magic over time.
The key is to find businesses with decent prospects trading at a reasonable enough valuation that you as a new investor have a chance to share in the benefits of that growth. It’s a balancing act, to be sure. Many of the hot growth businesses trade as though their growth will continue unabated forever, while many of the companies with cheap valuations don’t have particularly strong growth prospects. With that balance in mind, here’s why investing in these stocks now could make you a millionaire retiree.
Image source: Getty Images.
America’s population is aging rapidly, with the number of people 65 or older expected to exceed the number of children by 2034. As a general rule, the older you are, the more healthcare services you need and the more you’re spending on them. That makes health insurance giant Anthem (NYSE:ANTM) a company well positioned to benefit from that trend.
After all, under Obamacare mandates, insurers must spend at least 80% of the premiums they receive on medical costs. The higher the costs of serving its target population, the higher the premiums the company can collect while still meeting that requirement. With an older population generally requiring more healthcare services than a younger population, that demographic trend provides a built-in reason to believe Anthem’s business can continue to grow.
From a valuation perspective, Anthem recently traded hands at around 11.5 times its trailing earnings, and those earnings are expected to grow around a 14.5% clip over the next five years. That’s a reasonable price to pay for a company well positioned for what the future is likely to bring. Of course, there are risks attached as well. Primarily, if a fully socialized healthcare system were to be implemented in the United States, insurers like Anthem would find themselves out of business.
Still, it’s in part because of that risk that Anthem trades in the stock market at a reasonable price today. It’s also an example of why any well-designed asset allocation plan includes an aspect of diversification to protect against the loss of any one business or industry.
Image source: Getty Images.
When times are tough, people may start to fall behind on their bills. When that happens, debt collectors like PRA Group (NASDAQ:PRAA) help them figure out how to get their obligations paid off. It’s not a particularly glamorous business, but it is certainly a necessary one that stands to see an uptick in tough times.
On the flip side, it’s often easier to borrow money in strong economic times. Indeed, the common refrain is that the best time to borrow money is when you don’t need it. While boom times mean it’s more likely that debtors will be able to pay, that fact that it’s easier to borrow during those times also means more debt will likely be issued to marginal borrowers. That means that even when times are good, there will also likely be a need for collections agencies like PRA Group.
Thanks to a business model that should work in both good times and in bad ones, PRA Group has the potential to both survive the current reality and grow in the future. On average, analysts expect it to earn $2.94 per share in 2020 and $3.16 per share in 2021. In addition, it’s expected to be able to increase its profitability by more than 30% annualized over the next five years. At a recent price around $40.85 per share, investors are paying less than 14 times anticipated 2020 earnings for that potential.
There’s an old saying among investors that accounting profits are a matter of opinion, but dividends are a matter of fact. The unfortunate reality is that a lot of troubles can be temporarily papered over with aggressive accounting practices. Dividends, on the other hand, are much tougher to fake, since companies generally need to have cold, hard cash on hand to hand it out to their shareholders.
That makes Texas Instruments’ (NASDAQ:TXN) recent 17% increase in its dividend worth paying attention to. In an era where dividend cuts are common because of the COVID pandemic, any dividend increase is appreciated, and a double-digit one is certainly worth paying attention to. That dividend increase brings its payout to $3.60 per share per year, which offers investors a respectable 2.6% yield at recent prices.
Texas Instruments has increased its dividend for 16 consecutive years, showcasing a decent commitment to rewarding shareholders for the risks they take by investing. Analysts are expecting it to be able to continue to grow its earnings by around 10% annualized over the next five years, which gives decent reason to believe that dividend growth can continue as well.
An integrated circuit company well known for its calculators, Texas Instruments has product lines that cross industries as diverse as education, industrial, automotive, and communications. That broad reach means that its fortunes aren’t tied to one particular customer or product line, which also helps provide reason to believe its operations can be sustained virtually no matter what comes next.
Although Aetna, PRA Group, and Texas Instruments all operate in very different industries, they all have solid businesses today and decent paths to potential growth in the future. That combination makes them worthy of consideration as part of a portfolio designed to help you get to millionaire status by the time you retire.
Author: Chuck Saletta
Here’s the Dividend Stock Most Likely to Double by 2022
What do you think of when you hear the phrase “dividend stocks”? For many investors, the answers probably include something along the lines of “low-growth” and maybe even “boring.” Those descriptors apply to quite a few dividend stocks, but not all of them.
I can think of one stock that offers a relatively high dividend yield that’s anything but low-growth and boring. In my view, it’s arguably the one dividend stock most likely to double by 2022. The stock I have in mind is Innovative Industrial Properties (NYSE:IIPR).
Image source: Getty Images.
Innovative Industrial Properties (IIP) ranks as the leading real estate investment trust (REIT) focused on the medical cannabis industry. It’s the first and, so far, only cannabis-focused REIT to list its shares on the New York Stock Exchange.
I like companies with simple and solid business models. IIP checks both boxes. The company buys properties from medical cannabis operators, and then leases those properties back to the operators. Those leases nearly always are for long durations: The weighted-average remaining lease term for IIP’s properties is around 16 years.
If you think a cannabis-focused REIT stock can’t double in a short period of time, think again. Take a look at IIP’s performance over the last three years.
IIPR data by YCharts
My view is that IIP can easily double (or more) by the end of 2022. How? All IIP has to do is keep doing what it’s been doing — i.e., reinvesting any cash it accumulates into new properties to lease back to medical cannabis operators. At the end of 2018, IIP owned 11 properties. A year later, that number jumped to 46; today, it stands at 62.
There are two reasons why I think IIP will keep growing. First, the U.S. cannabis industry is smoking hot. Thirty-three states have already legalized medical cannabis. More could do so in the upcoming November elections. Second, the Federal Reserve Board intends to keep interest rates near zero through 2023. That means IIP’s borrowing costs will remain low.
I fully expect IIP’s number of properties to at least double by the end of 2022, driving its revenue, earnings, and stock price higher in the process. And, as they say on the TV infomercials, “But wait… there’s more!”
Remember that IIP is a REIT. That means the company must return a minimum of 90% of taxable income to shareholders in the form of dividends. So if IIP’s earnings double or more within the next 27 months, so will its dividend payout.
Here’s the great thing: IIP’s dividend yields north of 3.7% right now. Investors who buy the stock now could very well have an effective yield of more than 7% in a little over two years. Sure, the stock’s appreciation would likely keep the dividend yield from rising to that level. However, anyone who bought the stock at the current price would receive much higher dividends from their initial investment.
By the way, IIP’s dividend has grown more than its share price over the last three years. Quite a bit more, actually.
IIPR data by YCharts
Dividends boost total returns. IIP stock really wouldn’t have to double by the end of 2022 for investors to double their initial investment, especially with dividend increases along the way.
Are there any potential gotchas? There are risks that apply to any stock, such as scandals and major geopolitical crises. I also think there’s another possible stumbling block that could reduce IIP’s prospects of doubling by 2022: marijuana legalization in the U.S.
IIP has enjoyed so much success partly because it doesn’t have significant competition from big players. Larger REITs have stayed away from the cannabis industry because of federal anti-marijuana laws. But if cannabis is legalized at the federal level, it could pave the way for more companies to enter the market. This increased competition would likely cause the lease rates charged to medical cannabis operators to fall.
It’s possible that the U.S. could be on the path to legalize medical cannabis at the federal level and change laws to recognize states’ rights to enforce their own recreational marijuana laws. My view is that’s exactly what will happen if the Democrat Party retakes the White House and the Senate.
However, even if more rivals come onto the scene, I still think IIP has a pretty good chance of doubling before 2022 is over. While U.S. marijuana legalization could increase competition for the company, it would also likely expand IIP’s market opportunities significantly. IIP should be the exact opposite of a boring, low-growth company over the next couple of years.
Author: Keith Speights
Biden Has $466 Million in Bank, and a Huge Financial Edge on Trump
The former vice president and the Democrats were $187 million behind President Trump and the Republicans this spring. Now they are entering the final stretch of the campaign with a $141 million advantage.
Joseph R. Biden Jr.’s campaign said on Sunday that it entered September with $466 million in the bank together with the Democratic Party, providing Mr. Biden a vast financial advantage of about $141 million over President Trump heading into the intense final stretch of the campaign.
The money edge is a complete reversal from this spring, when Mr. Biden emerged as the Democratic nominee and was $187 million behind Mr. Trump, who began raising money for his re-election shortly after he was inaugurated in 2017. But the combination of slower spending by Mr. Biden’s campaign in the spring, his record-setting fund-raising over the summer — especially after he named Senator Kamala Harris of California as his running mate — and heavy early spending by Mr. Trump has erased the president’s once-formidable financial lead.
Mr. Trump and his joint operations with the Republican National Committee entered September with $325 million, according to Mr. Trump’s communications director, Tim Murtaugh.
The Trump campaign pulled back on its television spending in August to conserve money, as some campaign insiders fretted about a cash crunch in the closing stretch of the campaign. But other officials argued that the Trump campaign would continue to raise heavily from small donors and that the cutbacks over the summer were shortsighted.
In the last four weeks of August, the Biden campaign spent $65.5 million on television advertising, compared with $18.7 million by the Trump campaign, according to data from Advertising Analytics.
Even after the reduction in TV ad spending, Federal Election Commission filings made public late Sunday showed Mr. Trump’s campaign committee ended August having raised $61.7 million and spent $61.2 million, along with adding about $900,000 in debt.
Money in the candidate’s own committees, as opposed to the political party’s account, is the most valuable of funds because election rules require those accounts to pay for certain types of spending, such as television ads.
Mr. Biden’s campaign committee reported raising $212 million and spending $130.3 million — banking more than $80 million last month.
Democratic donations surged further over the weekend. Following the death of former Justice Ruth Bader Ginsburg, which opened a vacancy that could tilt the ideological bearing of the Supreme Court further to the right, contributors shattered records on ActBlue, the biggest online processing platform for the left.
Donors gave more than $100 million over the weekend after her passing.
Before the latest presidential disclosures were filed, some Republicans were questioning how a Trump campaign that has raised $1.3 billion since the beginning of 2019 with the Republican National Committee has already spent nearly $1 billion of those funds before the start of voting. Trump officials have repeatedly pointed to their bigger investment in ground operations (such as door-to-door canvassing) that Democrats have forgone during the pandemic as prudent spending that will provide a benefit as balloting begins.
“Our early investment in states is going to move the needle in a way that Joe Biden’s campaign just can’t do, even if they tried starting now,” Bill Stepien, Mr. Trump’s campaign manager, told reporters this month.
An extraordinary influx of cash in August accounts for Mr. Biden’s newfound financial lead, after he and the Republicans entered the month nearly neck and neck. The Biden campaign and his joint operations with the Democratic National Committee raised a record $364.5 million last month — more than any previous candidate has raised in a single month — while Mr. Trump brought in $210 million, their campaigns said.
“It’s hard to even get your head around the size and historic nature of this,” Jennifer O’Malley Dillon, Mr. Biden’s campaign manager, said in a call with reporters this month. The cash-on-hand figure released by the campaign shows it spent about $192 million, barely over half of what it brought in last month.
“We’re going to have the resources, not just to go wide on our map but also to go deep within those states,” Ms. Dillon said of the Electoral College battlegrounds.
Billionaires and very wealthy supporters continue to exert their influence on the race through super PACs, which have no limits on giving. New filings showed Kelcy Warren, an oil pipeline billionaire, gave $10 million to a pro-Trump super PAC, America First Action, along with $2 million from Diane Hendricks, a Wisconsin billionaire, and $1 million from three others.
On the Democratic side, Michael R. Bloomberg, the former mayor of New York City who ran unsuccessfully in the Democratic presidential primary, recently announced he would spend $100 million supporting Mr. Biden in Florida, by far the largest and most expensive electoral prize. James Murdoch, the son of the Fox media mogul Rupert Murdoch, donated $300,000 in August to a pro-Biden super PAC, Unite the Country.
The monthly financial filings for both the Trump and Biden camps made on Sunday offered only a partial window into the state of the money race, as some of their joint committees with the parties will not have to file until next month.
On Sunday, the R.N.C. reported a second payment of $666,666.67 to Reuters News & Media in August labeled “legal proceedings — IP resolution.” An identically sized and labeled payment was made in June. Reuters and the R.N.C. previously declined to comment on the first such payment.
Katie Glueck and Rachel Shorey contributed reporting.
Author: Shane Goldmacher